Biomarkers in 5q-associated spinal muscular atrophy—a narrative review H. S. LappM. FreigangRené Günther Review Open access 08 June 2023 Pages: 4157 - 4178
The correlation between 9-HPT and patient-reported measures of upper limb function in multiple sclerosis: a systematic review and meta-analysis Erica GrangeClaudio SolaroDavide Marengo Review Open access 09 June 2023 Pages: 4179 - 4191
Safety and efficacy of intravenous thrombolysis in patients with acute ischemic stroke taking direct oral anticoagulants prior to stroke: a meta-analysis Huo LiangXue WangZhijian Liang Review 14 June 2023 Pages: 4192 - 4200
Comorbidity of epilepsy and attention-deficit/hyperactivity disorder: a systematic review and meta-analysis Shun WangBaozhen YaoZhongchun Liu Review 16 June 2023 Pages: 4201 - 4213
Impacts of exposure to ambient temperature and altitude on the burden of stroke Wen-Jun TuYicheng XuJizong Zhao Original Communication 11 May 2023 Pages: 4214 - 4218
Adult-onset leukodystrophy with vanishing white matter: a case series of 19 patients Chiara BenzoniMarco MoscatelliEttore Salsano Original Communication 12 May 2023 Pages: 4219 - 4234
Presymptomatic grey matter alterations in ALS kindreds: a computational neuroimaging study of asymptomatic C9orf72 and SOD1 mutation carriers Peter BedeDorothée LuléJan Kassubek Original Communication Open access 13 May 2023 Pages: 4235 - 4247
Diagnostic and prognostic performance of plasma neurofilament light chain in multiple system atrophy: a cross-sectional and longitudinal study Linliu PengLinlin WanHong Jiang Original Communication 15 May 2023 Pages: 4248 - 4261
Oculomotor abnormalities indicate early executive dysfunction in prodromal X-linked dystonia-parkinsonism (XDP) Renana MertinCid DiestaAndreas Sprenger Original Communication Open access 16 May 2023 Pages: 4262 - 4275
The longitudinal progression of MRI changes in pre-ataxic carriers of SCA3/MJD Camila Maria de OliveiraVanessa Bielefeldt LeottiLaura Bannach Jardim Original Communication 16 May 2023 Pages: 4276 - 4287
Effectiveness and safety of rituximab in autoimmune nodopathy: a single-center cohort study Bingyou LiuJianian HuChongbo Zhao Original Communication 17 May 2023 Pages: 4288 - 4295
Functional and structural brain MRI changes associated with cognitive worsening in multiple sclerosis: a 3-year longitudinal study Matteo AzzimontiPaolo PreziosaMassimo Filippi Original Communication 18 May 2023 Pages: 4296 - 4308
Digital measures of freezing of gait across the spectrum of normal, non-freezers, possible freezers and definite freezers Martina ManciniNaoya HasegawaJohn G. Nutt Original Communication 19 May 2023 Pages: 4309 - 4317
Identifying large vessel occlusion at first glance in telemedicine Nils SchröterAntonia WeillerLena-Alexandra Beume Original Communication Open access 18 May 2023 Pages: 4318 - 4325
A cross-sectional study on the neurocognitive outcomes in vestibular impaired school-aged children: are they at higher risk for cognitive deficits? Ruth Van HeckeMaya DanneelsLeen Maes Original Communication 20 May 2023 Pages: 4326 - 4341
Long-term effects of bilateral subthalamic nucleus deep brain stimulation on gait disorders in Parkinson’s disease: a clinical-instrumental study Francesco CavallieriIsabella CampaniniFranco Valzania Original Communication 20 May 2023 Pages: 4342 - 4353
Intravenous thrombolysis and mechanical recanalization for acute ischemic stroke in deep brain stimulation patients: a case series Johannes MeyneMirjam DomschikowskiSteffen Paschen Original Communication Open access 22 May 2023 Pages: 4354 - 4359
The “Vestibular Eye Sign”—“VES”: a new radiological sign of vestibular neuronitis can help to determine the affected vestibule and support the diagnosis Raed FarhatAnan Abu AwadSaqr Massoud Original Communication Open access 23 May 2023 Pages: 4360 - 4367
Tumefactive brain parenchymal neurosarcoidosis Gabriela A. BouSally El SammakSpencer K. Hutto Original Communication 23 May 2023 Pages: 4368 - 4376
Could efficacy at 1 week after galcanezumab administration for patients with migraine predict responders at 3 months? A real world study Keisuke SuzukiShiho SuzukiKoichi Hirata Original Communication 23 May 2023 Pages: 4377 - 4384
Reduced 123I-MIBG uptake in the parotid and submandibular glands in patients with Parkinson’s disease identified using a quantitative semi-automatic method Junya EbinaSunao MizumuraOsamu Kano Original Communication 24 May 2023 Pages: 4385 - 4392
Neurofilament light chain and cardiac MIBG uptake as predictors for phenoconversion in isolated REM sleep behavior disorder Don Gueu ParkJu Yeong KimJung Han Yoon Original Communication 26 May 2023 Pages: 4393 - 4402
A randomized double-blind placebo-controlled trial of low-dose interleukin-2 in relapsing–remitting multiple sclerosis C. LouapreM. RosenzwajgD. Klatzmann Original Communication 28 May 2023 Pages: 4403 - 4414
Progression of initially unilateral Moyamoya angiopathy in Caucasian Europeans Daniel StrunkRolf R. DiehlMarkus Kraemer Original Communication 01 June 2023 Pages: 4415 - 4422
Assessing balance in people with bilateral vestibulopathy using the Mini-Balance Evaluation Systems Test (Mini-BESTest): feasibility and comparison with healthy control data Meichan ZhuLisa van StiphoutChristopher McCrum Original Communication Open access 03 June 2023 Pages: 4423 - 4433
Morphological and molecular comparison of HIV-associated and sporadic inclusion body myositis Sinja VogtFelix KleefeldKatrin Hahn Original Communication Open access 06 June 2023 Pages: 4434 - 4443
Association between peripheral adaptive immune markers and disease progression in Parkinson's disease Yi XiaoQianqian WeiHuifang Shang Original Communication 06 June 2023 Pages: 4444 - 4450
The prevalence and incidence of progressive supranuclear palsy and corticobasal syndrome: a systematic review and meta-analysis Shane LyonsDominic TrépelSean O’Dowd Original Communication Open access 08 June 2023 Pages: 4451 - 4465
Analysis and hierarchical clustering of infratentorial morphological MRI identifies SCAs phenogroups Jing ZhaoWenting ZengJianping Chu Original Communication 08 June 2023 Pages: 4466 - 4477
Neurodegeneration in the retina of motoneuron diseases: a longitudinal study in amyotrophic lateral sclerosis and Kennedy’s disease Alessandro MisciosciaMarco PuthenparampilPaolo Gallo Original Communication Open access 08 June 2023 Pages: 4478 - 4486
Risk and protective factors in Parkinson's disease: a simultaneous and prospective study with classical statistical and novel machine learning models Alessandro GialluisiMaria Ilenia De BartoloLicia Iacoviello Original Communication 09 June 2023 Pages: 4487 - 4497
Clinical features and maternal and fetal outcomes in women with Guillain-Barré syndrome in pregnancy Nolwenn KriefRené GabrielAndoni Echaniz-Laguna Original Communication 09 June 2023 Pages: 4498 - 4506
Pupillometry in the follow-up of patients undergoing EVT - prediction of space-occupying hemispheric infarction Clara-Sophie KosselFranca KobusJulia Koehn Original Communication Open access 10 June 2023 Pages: 4507 - 4517
Real-world experience with VMAT2 inhibitors in Tourette syndrome Karim MakhoulJoseph Jankovic Original Communication 11 June 2023 Pages: 4518 - 4522
TS-HDS autoantibody: clinical characterization and utility from real-world tertiary care center experience Pitcha ChompoopongMohamed RezkDivyanshu Dubey Short Commentary 09 June 2023 Pages: 4523 - 4528
Neuromyelitis optica spectrum disorder with a familial Mediterranean fever gene E84K mutation Naoko NakamuraHidehiro IshikawaHidekazu Tomimoto Letter to the Editors 03 May 2023 Pages: 4529 - 4532
The expanding spectrum of antibody-associated cerebellar ataxia: report of two new cases of anti-AP3B2 ataxia Andreu VilasecaLe-Duy DoJérôme Honnorat Letter to the Editors 03 May 2023 Pages: 4533 - 4537
PLIN4-related myopathy: clinical, histological and imaging data in a large cohort of patients Lorenzo MaggiSara GibertiniAlessandra Ruggieri Letter to the Editors Open access 05 May 2023 Pages: 4538 - 4543
RNA interference in late-stage hereditary transthyretin amyloidosis: a clinicopathological study Goichi BeckYuki YonenobuHideki Mochizuki Letter to the Editors 08 May 2023 Pages: 4544 - 4548
Image features of anti-SEZ6L2 encephalitis, a rare cause of ataxia and parkinsonism Dingding ShenQinming ZhouSheng Chen Letter to the Editors 10 May 2023 Pages: 4549 - 4553
Correction to: Image features of anti‑SEZ6L2 encephalitis, a rare cause of ataxia and parkinsonism Dingding ShenQinming ZhouSheng Chen Correction 19 July 2023 Pages: 4554 - 4554
Eculizumab for the treatment of glycine receptor antibody associated stiff-person syndrome Jennifer A. McCombeBryan T. KlassenAndrew McKeon Letter to the Editors Open access 18 May 2023 Pages: 4555 - 4557
Neurological update: non-motor symptoms in atypical parkinsonian syndromes Piriyankan AnanthavarathanB. PatelN. Malek Neurological Update Open access 15 June 2023 Pages: 4558 - 4578
Clinical trials in myasthenia gravis A. MahmoodJ. HawkenN. P. Robertson Journal club Open access 31 July 2023 Pages: 4579 - 4581
Correction to: Encephalitis in HIV‑infected adults in the antiretroviral therapy era Melissa Reimer-McAteeDenisse RamirezRodrigo Hasbun Correction 05 June 2023 Pages: 4582 - 4582
Correction to: Safety and effectiveness of ataluren in patients with nonsense mutation DMD in the STRIDE Registry compared with the CINRG Duchenne Natural History Study (2015–2022): 2022 interim analysis Eugenio MercuriAndrés Nascimento Osoriothe STRIDE and CINRG DNHS investigators Correction Open access 17 July 2023 Pages: 4583 - 4583
